Sacroiliitis as an Initial Manifestation of Acute Myelogenous Leukemia

被引:0
作者
Takumi Hoshino
Takafumi Matsushima
Yasuyuki Saitoh
Arito Yamane
Makiko Takizawa
Hiroyuki Irisawa
Takayuki Saitoh
Hiroshi Handa
Norifumi Tsukamoto
Masamitsu Karasawa
Hirokazu Murakami
Yoshihisa Nojima
机构
[1] Gunma University Graduate School of Medicine,Department of Medicine and Clinical Science
[2] Gunma University,School of Health Sciences Faculty of Medicine
[3] Gunma University Hospital,Division of Blood Transfusion Service
来源
International Journal of Hematology | 2006年 / 84卷
关键词
Sacroiliitis; AML; AS;
D O I
暂无
中图分类号
学科分类号
摘要
Sacroiliitis is the most pathognomonic and earliest manifestation of ankylosing spondylitis.We herein report a 28-year-old female patient who presented with sacroiliitis as an initial manifestation of acute myelogenous leukemia (AML). She had a 3-month history of anemia and walking difficulty. Bone marrow findings revealed an increase of blasts with trilineage dysplasia. Although she was initially diagnosed with myelodysplastic syndrome (MDS), blasts rapidly increased and AML developed 1 month after the diagnosis of MDS with sacroiliitis. Induction chemotherapy failed to induce a complete remission of AML, but it did effectively treat the sacroiliitis. However, the sacroiliitis relapsed when the leukemia cells progressed thereafter. Oral corticosteroids helped ameliorate the sacroiliitis. She underwent bone marrow transplantation (BMT) from an HLA-identical sister during a nonremission period; however, the leukemic cells began to rapidly increase from day 30 after BMT. The close relationship between the occurrence of sacroiliitis and AML suggested that autoimmune sacroiliitis was a paraneoplastic phenomenon of AML in this patient. Although autoimmune disorders develop in a substantial number of MDS patients, they are rarely observed in de novo AML. No previous report has described sacroiliitis as the initial manifestation of de novo AML.
引用
收藏
页码:421 / 424
页数:3
相关论文
共 50 条
  • [21] The clinically relevant pharmacogenomic changes in acute myelogenous leukemia
    Emadi, Ashkan
    Karp, Judith E.
    PHARMACOGENOMICS, 2012, 13 (11) : 1257 - 1269
  • [22] Rhizopus microsporus typhlitis in a patient with acute myelogenous leukemia
    Trybula, Marcus
    Wang, Diping
    Baumann, Lauren
    Pritts, Timothy A.
    Hambley, Bryan C.
    CLINICAL CASE REPORTS, 2021, 9 (06):
  • [23] Checkpoint inhibitors and acute myelogenous leukemia: promises and challenges
    Alfayez, Mansour
    Borthakur, Gautam
    EXPERT REVIEW OF HEMATOLOGY, 2018, 11 (05) : 373 - 389
  • [24] Cytokines, molecular biological abnormalities, and acute myelogenous leukemia
    Preisler, HD
    Bi, S
    Venugopal, P
    Raza, A
    LEUKEMIA RESEARCH, 1997, 21 (04) : 299 - 312
  • [25] Detection of minimal residual disease in acute myelogenous leukemia
    Raanani, P
    Ben-Bassat, I
    ACTA HAEMATOLOGICA, 2004, 112 (1-2) : 40 - 54
  • [26] Nucleophosmin mutations in Chinese adults with acute myelogenous leukemia
    Ruan, Guo-Rui
    Li, Jin-Lan
    Qin, Ya-Zhen
    Li, Ling-Di
    Xie, Min
    Chang, Yan
    Zhang, Yan
    Liu, Yan-Rong
    Jiang, Bin
    Chen, Shan-Shan
    Huang, Xiao-Jun
    ANNALS OF HEMATOLOGY, 2009, 88 (02) : 159 - 166
  • [27] Central Diabetes Insipidus in the Setting of Acute Myelogenous Leukemia
    Dy, Pearl
    Chua, Patrick
    Kelly, Jennifer
    Liebman, Scott
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 60 (06) : 998 - 1001
  • [28] CELLULAR CYTOTOXIC FUNCTION AND POTENTIAL IN ACUTE MYELOGENOUS LEUKEMIA
    LIM, SH
    WORMAN, CP
    JEWELL, AP
    GOLDSTONE, AH
    LEUKEMIA RESEARCH, 1991, 15 (07) : 641 - 644
  • [29] ALLOGENEIC TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKEMIA - ARE WE STUCK
    BUCKNER, CD
    CLIFT, RA
    LEUKEMIA & LYMPHOMA, 1993, 11 : 25 - 28
  • [30] GRANULOCYTIC SARCOMA OF THE OVARY IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA
    YAMAMOTO, K
    AKIYAMA, H
    MARUYAMA, T
    SAKAMAKI, H
    ONOZAWA, Y
    KAWAGUCHI, K
    AMERICAN JOURNAL OF HEMATOLOGY, 1991, 38 (03) : 223 - 225